Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor.

Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, Popovic Z, McCarthy PM, Penn MS.

Stem Cells. 2007 Jan;25(1):245-51. Epub 2006 Oct 19.

2.
3.
4.

Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study.

Jiang W, Ma A, Wang T, Han K, Liu Y, Zhang Y, Dong A, Du Y, Huang X, Wang J, Lei X, Zheng X.

Pflugers Arch. 2006 Oct;453(1):43-52. Epub 2006 Aug 17.

PMID:
16915405
5.

Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction.

Sun L, Cui M, Wang Z, Feng X, Mao J, Chen P, Kangtao M, Chen F, Zhou C.

Biochem Biophys Res Commun. 2007 Jun 8;357(3):779-84. Epub 2007 Apr 11.

PMID:
17445769
6.

Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury.

Iop L, Chiavegato A, Callegari A, Bollini S, Piccoli M, Pozzobon M, Rossi CA, Calamelli S, Chiavegato D, Gerosa G, De Coppi P, Sartore S.

Cell Transplant. 2008;17(6):679-94.

PMID:
18819256
7.

Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.

Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE, Ikeda U.

Circ Res. 2006 Oct 13;99(8):891-9. Epub 2006 Sep 21.

8.

Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation.

Feygin J, Mansoor A, Eckman P, Swingen C, Zhang J.

Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1772-80. Epub 2007 Jun 15.

9.

Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.

Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, L├╝tzow K, Lendlein A, Stamm C, Li RK, Steinhoff G.

Stem Cells. 2007 Aug;25(8):2118-27. Epub 2007 May 3.

10.

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

Dwyer RM, Potter-Beirne SM, Harrington KA, Lowery AJ, Hennessy E, Murphy JM, Barry FP, O'Brien T, Kerin MJ.

Clin Cancer Res. 2007 Sep 1;13(17):5020-7.

11.

Stromal cell-derived factor-1 and monocyte chemotactic protein-3 improve recruitment of osteogenic cells into sites of musculoskeletal repair.

Shinohara K, Greenfield S, Pan H, Vasanji A, Kumagai K, Midura RJ, Kiedrowski M, Penn MS, Muschler GF.

J Orthop Res. 2011 Jul;29(7):1064-9. doi: 10.1002/jor.21374. Epub 2011 Feb 24.

12.

Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells.

Song H, Chang W, Lim S, Seo HS, Shim CY, Park S, Yoo KJ, Kim BS, Min BH, Lee H, Jang Y, Chung N, Hwang KC.

Stem Cells. 2007 Jun;25(6):1431-8. Epub 2007 Mar 8.

13.

Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction.

Pak HN, Qayyum M, Kim DT, Hamabe A, Miyauchi Y, Lill MC, Frantzen M, Takizawa K, Chen LS, Fishbein MC, Sharifi BG, Chen PS, Makkar R.

J Cardiovasc Electrophysiol. 2003 Aug;14(8):841-8.

PMID:
12890047
14.

Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.

Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, Kaps C, Sittinger M.

J Cell Biochem. 2007 May 1;101(1):135-46.

PMID:
17295203
15.

Monocyte chemotactic protein-1 promotes the myocardial homing of mesenchymal stem cells in dilated cardiomyopathy.

Guo J, Zhang H, Xiao J, Wu J, Ye Y, Li Z, Zou Y, Li X.

Int J Mol Sci. 2013 Apr 15;14(4):8164-78. doi: 10.3390/ijms14048164.

16.

Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction.

Wang CC, Chen CH, Lin WW, Hwang SM, Hsieh PC, Lai PH, Yeh YC, Chang Y, Sung HW.

Cardiovasc Res. 2008 Feb 1;77(3):515-24. Epub 2007 Oct 19.

PMID:
18006453
17.

Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.

Wang YQ, Wang M, Zhang P, Song JJ, Li YP, Hou SH, Huang CX.

Chin Med J (Engl). 2008 Nov 20;121(22):2290-8.

PMID:
19080335
18.

Focused ultrasound-induced stimulation of microbubbles augments site-targeted engraftment of mesenchymal stem cells after acute myocardial infarction.

Ghanem A, Steingen C, Brenig F, Funcke F, Bai ZY, Hall C, Chin CT, Nickenig G, Bloch W, Tiemann K.

J Mol Cell Cardiol. 2009 Sep;47(3):411-8. doi: 10.1016/j.yjmcc.2009.06.008. Epub 2009 Jun 21.

PMID:
19540842
19.

Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis.

Ohnishi S, Yanagawa B, Tanaka K, Miyahara Y, Obata H, Kataoka M, Kodama M, Ishibashi-Ueda H, Kangawa K, Kitamura S, Nagaya N.

J Mol Cell Cardiol. 2007 Jan;42(1):88-97. Epub 2006 Nov 13.

PMID:
17101147
20.

Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction.

Hu X, Wang J, Chen J, Luo R, He A, Xie X, Li J.

Eur J Cardiothorac Surg. 2007 Mar;31(3):438-43. Epub 2007 Jan 17.

PMID:
17239611

Supplemental Content

Support Center